Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Quantitative Measurement of Anti-SARS-CoV-2 Antibodies: Analytical and Clinical Evaluation
Victoria Higgins, Anselmo Fabros, Vathany Kulasingam
Journal of Clinical Microbiology (2021) Vol. 59, Iss. 4
Open Access | Times Cited: 128

Showing 1-25 of 128 citing articles:

Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients
Brian J. Boyarsky, William A. Werbel, Robin K. Avery, et al.
JAMA (2021) Vol. 325, Iss. 17, pp. 1784-1784
Open Access | Times Cited: 523
SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunity
Daniel Mrak, Selma Tobudic, Maximilian Koblischke, et al.
Annals of the Rheumatic Diseases (2021) Vol. 80, Iss. 10, pp. 1345-1350
Closed Access | Times Cited: 232
Systemic IL-15, IFN-γ, and IP-10/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients
Cristina Bergamaschi, Evangelos Terpos, Margherita Rosati, et al.
Cell Reports (2021) Vol. 36, Iss. 6, pp. 109504-109504
Open Access | Times Cited: 184
Antibody response to a single dose of SARS-CoV-2 mRNA vaccine in patients with rheumatic and musculoskeletal diseases
Brian J. Boyarsky, Jake A. Ruddy, Caoilfhionn M Connolly, et al.
Annals of the Rheumatic Diseases (2021) Vol. 80, Iss. 8, pp. 1098-1099
Open Access | Times Cited: 179
Anti-Spike Protein Assays to Determine SARS-CoV-2 Antibody Levels: a Head-to-Head Comparison of Five Quantitative Assays
Thomas Perkmann, Nicole Perkmann‐Nagele, Thomas Köller, et al.
Microbiology Spectrum (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 177
Analysis of antibody responses after COVID-19 vaccination in liver transplant recipients and those with chronic liver diseases
Paul J. Thuluvath, Polly Robarts, Mahak Chauhan
Journal of Hepatology (2021) Vol. 75, Iss. 6, pp. 1434-1439
Open Access | Times Cited: 148
Response to SARS-CoV-2 vaccination in patients after hematopoietic cell transplantation and CAR T-cell therapy
Binod Dhakal, Sameem Abedin, Timothy S. Fenske, et al.
Blood (2021) Vol. 138, Iss. 14, pp. 1278-1281
Open Access | Times Cited: 124
High antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with rheumatic and musculoskeletal diseases
Jake A. Ruddy, Caoilfhionn M Connolly, Brian J. Boyarsky, et al.
Annals of the Rheumatic Diseases (2021) Vol. 80, Iss. 10, pp. 1351-1352
Open Access | Times Cited: 123
Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in persons with HIV
Jake A. Ruddy, Brian J. Boyarsky, Justin R. Bailey, et al.
AIDS (2021) Vol. 35, Iss. 14, pp. 2399-2401
Open Access | Times Cited: 71
Performance evaluation of three automated quantitative immunoassays and their correlation with a surrogate virus neutralization test in coronavirus disease 19 patients and pre‐pandemic controls
Kiwook Jung, Sue Shin, Minjeong Nam, et al.
Journal of Clinical Laboratory Analysis (2021) Vol. 35, Iss. 9
Open Access | Times Cited: 65
Immunogenicity and Reactogenicity After SARS-CoV-2 mRNA Vaccination in Kidney Transplant Recipients Taking Belatacept
Michael T. Ou, Brian J. Boyarsky, Teresa Po‐Yu Chiang, et al.
Transplantation (2021) Vol. 105, Iss. 9, pp. 2119-2123
Open Access | Times Cited: 61
SARS-CoV-2 messenger RNA vaccine antibody response and reactogenicity in heart and lung transplant recipients
Andrew M. Hallett, Ross S. Greenberg, Brian J. Boyarsky, et al.
The Journal of Heart and Lung Transplantation (2021) Vol. 40, Iss. 12, pp. 1579-1588
Open Access | Times Cited: 61
Temporary hold of mycophenolate augments humoral response to SARS-CoV-2 vaccination in patients with rheumatic and musculoskeletal diseases: a case series
Caoilfhionn M Connolly, Teresa Po‐Yu Chiang, Brian J. Boyarsky, et al.
Annals of the Rheumatic Diseases (2021) Vol. 81, Iss. 2, pp. 293-295
Closed Access | Times Cited: 56
Protective roles and protective mechanisms of neutralizing antibodies against SARS-CoV-2 infection and their potential clinical implications
Endeshaw Chekol Abebe, Tadesse Asmamaw Dejenie
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 35
SARS-CoV-2-reactive antibody waning, booster effect and breakthrough SARS-CoV-2 infection in hematopoietic stem cell transplant and cell therapy recipients at one year after vaccination
José Luís Piñana, Rodrigo Martino, Lourdes Vázquez, et al.
Bone Marrow Transplantation (2023) Vol. 58, Iss. 5, pp. 567-580
Open Access | Times Cited: 24
Reviewing methods of deep learning for diagnosing COVID-19, its variants and synergistic medicine combinations
Qandeel Rafique, Ali Rehman, Muhammad Sher Afghan, et al.
Computers in Biology and Medicine (2023) Vol. 163, pp. 107191-107191
Open Access | Times Cited: 22
Standardised quantitative assays for anti-SARS-CoV-2 immune response used in vaccine clinical trials by the CEPI Centralized Laboratory Network: a qualification analysis
Mark Manak, Luc Gagnon, Steven Phay-Tran, et al.
The Lancet Microbe (2024) Vol. 5, Iss. 3, pp. e216-e225
Open Access | Times Cited: 8
Absence of Humoral Response After Two-Dose SARS-CoV-2 Messenger RNA Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: A Case Series
Caoilfhionn M Connolly, Brian J. Boyarsky, Jake A. Ruddy, et al.
Annals of Internal Medicine (2021) Vol. 174, Iss. 9, pp. 1332-1334
Open Access | Times Cited: 54
Evaluation of SARS-CoV-2 Spike Protein Antibody Titers in Cord Blood after COVID-19 Vaccination during Pregnancy in Polish Healthcare Workers: Preliminary Results
Wojciech Zdanowski, Tomasz Waśniewski
Vaccines (2021) Vol. 9, Iss. 6, pp. 675-675
Open Access | Times Cited: 51
Safety and antibody response to the first dose of severe acute respiratory syndrome coronavirus 2 messenger RNA vaccine in persons with HIV
Jake A. Ruddy, Brian J. Boyarsky, William A. Werbel, et al.
AIDS (2021) Vol. 35, Iss. 11, pp. 1872-1874
Open Access | Times Cited: 47
Covid-19 in patients with chronic lymphocytic leukemia: clinical outcome and B- and T-cell immunity during 13 months in consecutive patients
Lisa Blixt, Gordana Bogdanović, Marcus Buggert, et al.
Leukemia (2021) Vol. 36, Iss. 2, pp. 476-481
Open Access | Times Cited: 40
B Cell Depletion and SARS‐CoV‐2 Vaccine Responses in Neuroimmunologic Patients
Barbara Kornek, Fritz Leutmezer, Paulus Rommer, et al.
Annals of Neurology (2022) Vol. 91, Iss. 3, pp. 342-352
Open Access | Times Cited: 36
Immunogenicity Following Administration of BNT162b2 and Ad26.COV2.S COVID-19 Vaccines in the Pregnant Population during the Third Trimester
Ioana Mihaela Citu, Cosmin Cîtu, Florin Gorun, et al.
Viruses (2022) Vol. 14, Iss. 2, pp. 307-307
Open Access | Times Cited: 35
Salivary IgG to SARS-CoV-2 indicates seroconversion and correlates to serum neutralization in mRNA-vaccinated immunocompromised individuals
Katie Healy, Elisa Pin, Puran Chen, et al.
Med (2022) Vol. 3, Iss. 2, pp. 137-153.e3
Open Access | Times Cited: 33
Neutralizing antibodies against SARS-CoV-2 variants of concern elicited by the comirnaty COVID-19 vaccine in nursing home residents
Beatriz Sánchez‐Sendra, Eliseo Albert, João Zulaica, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 29
Page 1 - Next Page

Scroll to top